NCT02786069View on ClinicalTrials.gov

A Single-dose Escalation Safety and PK Study for PLC in Healthy Chinese

PHASE1CompletedINTERVENTIONAL
Enrollment

16

Participants

Timeline

Start Date

June 30, 2015

Primary Completion Date

November 30, 2015

Study Completion Date

January 31, 2016

Conditions
Peripheral Arterial Disease
Interventions
DRUG

Propionyl L-carnitine Hydrochloride

500mg/ tablet; for oral administration, 1 dosage form is set for this trial: 1g, 2g and 4g.

Sponsors
All Listed Sponsors
lead

Lee's Pharmaceutical Limited

INDUSTRY